跳至主要内容
临床试验/CTRI/2024/02/063254
CTRI/2024/02/063254已完成2 期

Evauluating quality of life in cancer patients receiving BIO-BLISS THE SMART HEALTH ELIXIR as add on therapy-A single arm clinical study

A for Ayurveda1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年3月12日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
to evaluate the quality of life of cancer patients after the administration of bio-bliss sryup as an add on therapy

研究概览

简要总结

The present study is prospective and open labelled,single arm clinical study total duration of the study is 4 week and sample size is 30 to asses the changes the quality life of patients of cancer on the basis of WHO and FACT G after administration of BIO BLISS health elixer

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients of both gender aged 18-70 years dignosed patients of cancer of any origin in general patients who had on going or not taking any treatment like chemotherapy and or radiation therapy.

排除标准

  • patients who are not willing to participate in the study severely ill with many complication Any other condition which may jeopardize the study Any other condition in which the investigators opinion would preclude the subject from the participating.

结局指标

主要结局

to evaluate the quality of life of cancer patients after the administration of bio-bliss sryup as an add on therapy

时间窗: 4 weeks

次要结局

  • to evaluate changes in quality of life in cancer patient WHO and FACT G questioner changes before and after administration of intervention(4 weeks)

研究者

发起方
A for Ayurveda
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Aena V Pathak

J S Ayurveda Mahavidhyalaya college road Nadiad

研究点 (1)

Loading locations...

相似试验